This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Other. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Innovations in Parkinson’s Disease Treatment by Che-Hao Wu
Introduction
Che-Hao Wu, a notable inventor based in Taipei, Taiwan, is recognized for his pioneering work in therapeutic methods for neurological disorders. With a focus on Parkinson's disease and Parkinson's syndrome, Wu has developed a unique approach leveraging traditional Chinese medicine to address these debilitating conditions.
Latest Patents
Che-Hao Wu holds a patent for a "Method of Independent or Adjuvant Treatment of Parkinson's Disease and Parkinson's Syndrome." This innovative patent outlines a therapeutic method involving the administration of a Chinese medicine composition. The formulation comprises extracts from a variety of ingredients including Rhizoma Pinelliae, Rhizoma Atractylodis Macrocephalae, Poria, and other herbal components, which are known for their potential benefits in treating neurological ailments.
Career Highlights
Despite being associated with a company categorized as "Other," Che-Hao Wu's career is marked by significant contributions to the field of medical innovation. His research and development in using traditional remedies reflect his commitment to exploring alternative therapies in modern medicine.
Collaborations
Wu often collaborates with fellow research professionals, including Chen-Yu Lee and Yao-Nan Yuan. These collaborations enhance his research, allowing for a multidisciplinary approach to the treatment of Parkinson's disease, increasing the efficacy and reach of his innovative methods.
Conclusion
Che-Hao Wu stands out as a visionary inventor whose work on a therapeutic method for Parkinson's disease showcases the potential of integrating traditional medicine into contemporary treatment landscapes. With his unique patent, he contributes to the ongoing dialogue in the medical community about innovative approaches to long-standing health challenges.